Latest Antibiotic-resistant bacteria Stories
-- Supportive Evidence for No Active Enzyme Absorption into Bloodstream Observed in Phase 1 Studies -- ROCKVILLE, Md., March 19, 2015 /PRNewswire/ --
CHICAGO, March 17, 2015 /PRNewswire-USNewswire/ -- "MRSA is the number one problem (a medical error) in U.S.
Jvion, the leader in clinical predictive algorithms, announced the development of a Clostridium Difficile (C Diff) use case to help clinicians reduce the risk of deadly infections inside and outside
Leading advocacy and disease-awareness nonprofits applauds Centers for Disease Control & Prevention's new study that calls attention to nearly 500,000 Americans afflicted with Clostridium
RIDGEWOOD, N.J., Feb.
More than 100,000 of these infections developed among residents of U.S. nursing homes ATLANTA, Feb. 26, 2015 /PRNewswire-USNewswire/ -- Clostridium difficile (C.
--Validates Ability of Vestex Active Barrier Apparel to Protect Healthcare Workers and Patients by Reducing Bacteria on Clothing that Can Cause Hospital Acquired Infections-- ORLANDO,
Trial also demonstrates strong trends in secondary clinical endpoints AUSTIN, Texas, Feb.
-- First-in-Class Drug Candidate to Prevent C. difficile to Begin Phase 2 Testing in 1st Quarter 2015 -- ROCKVILLE, Md., Feb.
New test detects MRSA and SA, the leading causes of healthcare-associated infections worldwide PLEASANTON, Calif., Jan.
- A hairdresser.